WATSON 408 (Lisinopril 20 mg)
Pill with imprint WATSON 408 is Yellow, Round and has been identified as Lisinopril 20 mg. It is supplied by Watson Pharmaceuticals.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; alport syndrome; coronary artery disease (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 408
Lisinopril
- Imprint:
- WATSON 408
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
FD&C Yellow No. 5
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 63739-0350 | McKesson Packaging Services |
| 43063-0007 | PDRX Pharmaceuticals Inc. (repackager) |
More about lisinopril
- Lisinopril Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 466 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
Consumer resources
Other brands: Zestril, Prinivil, Qbrelis
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
